Jenny Nguyen, M.Sc.

jenguyen@coh.org
626-256-4673
Jenny Nguyen
Research Associate II, Department of Immuno-Oncology
Research Teams
Immuno-Oncology

Expertise

  • Western blot
  • Transfection
  • Transformation
  • Tissue Culture
  • DNA cloning
  • Recombinant DNA
  • Immunoprecipitation
  • Immunohistochemistry
  • Primary Cell Isolation
Location
Education & Experience
Professional Experience

  • 2018-present, Research Associate II, Department of Immuno-Oncology, City of Hope, Duarte, CA

  • 2016-2017, Research Associate II, Department of Experimental Therapeutics, City of Hope, Duarte, CA

  • 2014-2015, Research Specialist, Department of Molecular Biology, University of Southern California, Los Angeles, CA

  • 2012-2014, Graduate Research Assistant, Department of Pharmaceutical Sciences, Western University of Health Science, Pomona, CA

Publications
  • Chen TC, Cho HY, Wang W, Wetzel SJ, Singh A, Nguyen J, Hofman FM, Schonthal AH. A novel Temozolomide analog, NEO212, with enhanced activity against MGMT-positive melanoma in vitro and in vivo. Cancer Letters 2015; 358(2): 144-151. doi: 10.1016/j.canlet.2014.12.021
  • Chen TC, Cho HY, Wang W, Wetzel SJ, Singh A, Nguyen J, Hofman FM, Schonthal AH. Chemotherapeutic effect of a novel temozolomide analog on nasopharyngeal carcinoma in vitro and in vivo. Journal of Biomedical Science 2015; 22:71. doi:10.1186/s12929-015-0175-6
  • Erickson CE, Gul R, Blessing CP, Nguyen J, Liu T, Andresen B (2013) The β-blocker Nebivolol Is a GRK/β-arrestin Biased Agonist. PLoS ONE 2013; 8(8): 1-14. e71980. doi:10.1371/journal.pone.0071980